Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Discover the key Worldwide Dividend ETF Options you should consider for an income-focused portfolio. Learn how to compare dividend yields and risk profiles.
13,701 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A new law accelerates the federal solar credit sunset to December 31, 2025. Homeowners who installed in 2025 can stil...
A comeback that ends in minutes isn't just sports news—it’s a blueprint for financial planning. Learn how to shield y...
A bold 17-inch Wimbledon hat by a global star sparked more than fashion chatter — it raised real questions about cost...
Ratepayers may be paying more as grid upgrades to support data centers roll out. A PJM-wide assessment estimates roug...
When a top executive sells a large block of stock, investors want to know whether it signals trouble or simply person...
A trading halt and a sharp drop put Lucid in the spotlight, but the company pushed back on bankruptcy chatter. This g...
A routine call turned into a financial nightmare when a fraudster impersonated Chase Bank, guiding a victim to transf...
AI champions are racing to fund data centers, but the debt that fuels this surge is drawing scrutiny. This guide expl...